TrialBMJ open2020

Prognostic value of 12 novel cardiological biomarkers in stable coronary artery disease. A 10-year follow-up of the placebo group of the Copenhagen CLARICOR trial.

Per Winkel et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.